The role of female hormonal factors in the development of rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 56, Issue 8, 2017, Pages 1254-1263

  Alpízar Rodríguez, Deshiré ^a   Pluchino, Nicola ^a,b   Canny, Geraldine ^c   Gabay, Cem ^a   Finckh, Axel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EPFL   (Switzerland)

Author keywords

Female hormonal factors; Reproductive factors; Rheumatoid arthritis; Risk factors; Women's health

Indexed keywords

ANTIESTROGEN; SEX HORMONE; ESTROGEN; PROGESTERONE;

BREAST FEEDING; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; ORAL CONTRACEPTIVE USE; OVARY POLYCYSTIC DISEASE; PARITY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMATIC REVIEW; AUTOIMMUNITY; BLOOD; IMMUNOLOGY; SEX DIFFERENCE;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; ESTROGENS; FEMALE; GONADAL HORMONES; HUMANS; PROGESTERONE; RISK FACTORS; SEX FACTORS;

EID: 85028312334     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew318     Document Type: Review

References (99)

1. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007;28:1-6.
2. Barragán-Martińez C, Amaya-Amaya J, Pineda-Tamayo R et al. Gender differences in Latin-American patients with rheumatoid arthritis. Gend Med 2012;9: 490-510. e5.
3. de Hair MJ, Lehmann KA, van de Sande MG et al. The clinical picture of rheumatoid arthritis according to the 2010 American College of Rheumatology/European League Against Rheumatism criteria: is this still the same disease? Arthritis Rheum 2012;64:389-93.
4. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
5. Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 2006;1069:212-22.
6. Masi AT. Incidence of rheumatoid arthritis: do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis? Br J Rheumatol 1994;33:697-9.
7. Goemaere S, Ackerman C, Goethals K et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990;17:1620-2.
8. Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol 2013;149:211-8.
9. Gold EB, Crawford SL, Avis NE et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol 2013;178:70-83.
10. Ramos-Remus C, Sierra-Jimenez G, Skeith K et al. Latitude gradient influences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 2007;26:1725-8.
11. Sokka T, Toloza S, Cutolo M et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009;11:R7.
12. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
13. Jorgensen KT, Wiik A, Pedersen M et al. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008;67:860-6.
14. Karlson EW, Chibnik LB, Tworoger SS et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009;60:641-52.
15. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
16. Rantapää-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
17. Gerlag DM, Raza K, van Baarsen LG et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012;71:638-41.
18. Lawrence JS, Laine VA, de G. The epidemiology of rheumatoid arthritis in Northern Europe. Proc R Soc Med 1961;54:454-62.
19. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults. Vital Health Stat 1966;11:1-43.
20. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-74.
21. James WH. Rheumatoid arthritis, the contraceptive pill, and androgens. Ann Rheum Dis 1993;52:470-4.
22. Harlow SD, Gass M, Hall JE et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012;97:1159-68.
23. Berglin E, Kokkonen H, Einarsdottir E, Agren A, Rantapää Dahlqvist S. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in Northern Sweden: a case-control study. Scand J Rheumatol 2010;39: 454-60.
24. Cutolo M, Sulli A, Capellino S et al. Anti-TNF and sex hormones. Ann N Y Acad Sci 2006;1069:391-400.
25. Sapir-Koren R, Livshits G. Rheumatoid arthritis onset in postmenopausal women: Does the ACPA seropositive subset result from genetic effects, estrogen deficiency, skewed profile of CD4 T-cells, and their interactions? Mol Cell Endocrinol 2016;431:145-63.
26. Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatology 2008;47(Suppl 3):iii2-5.
27. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352-6.
28. Wilder RL. Hormones and autoimmunity: animal models of arthritis. Baillieres Clin Rheumatol 1996;10:259-71.
29. Raza K, Falciani F, Curnow SJ et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-95.
30. van Hamburg JP, Asmawidjaja PS, Davelaar N et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 2011;63:73-83.
31. Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 2014;13:668-77.
32. Andersson A, Stubelius A, Karlsson MN et al. Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis. Arthritis Res Ther 2015;17:32.
33. Khalid AB, Krum SA. Estrogen receptors alpha and beta in bone. Bone 2016;87:130-5.
34. Ishizuka M, Hatori M, Suzuki T et al. Sex steroid receptors in rheumatoid arthritis. Clin Sci 2004;106:293-300.
35. Kim OY, Chae JS, Paik JK et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age 2012;34:415-25.
36. Mateen S, Zafar A, Moin S, Khan AQ, Zubair S. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta 2016;455:161-71.
37. Pfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90-119.
38. Ralston SH, Russell RG, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990;5:983-8.
39. Sthoeger ZM, Chiorazzi N, Lahita RG. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol 1988;141:91-8.
40. Kissick HT, Sanda MG, Dunn LK et al. Androgens alter Tcell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci U S A 2014;111:9887-92.
41. Schwinge D, Carambia A, Quaas A et al. Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis. J Immunol 2015;194:2522-30.
42. Pikwer M, Giwercman A, Bergström U et al. Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann Rheum Dis 2014;73:573-9.
43. Cutolo M, Seriolo B, Villaggio B et al. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 2002;966:131-42.
44. Masi AT, Elmore KB, Rehman AA et al. Lower serum androstenedione levels in pre-rheumatoid arthritis versus normal control women: correlations with lower serum cortisol levels. Autoimmune Dis 2013;2013:593493.
45. Tengstrand B, Carlstrom K, Fellander-Tsai L, Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003;30:2338-43.
46. Schmidt M, Weidler C, Naumann H et al. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes-androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res Ther 2005;7: R938-48.
47. Castagnetta LA, Carruba G, Granata OM et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003;30:2597-605.
48. Cutolo M, Villaggio B, Seriolo B et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 2004;3:193-8.
49. Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: common pathway in both sexes. Ann N Y Acad Sci 2014;1317:24-31.
50. Hughes GC, Martin D, Zhang K et al. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis Rheum 2009;60:1775-84.
51. Kovacs WJ, Olsen NJ. Sexual dimorphism of RA manifestations: genes, hormones and behavior. Nat Rev Rheumatol 2011;7:307-10.
52. Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol 2014;10:740-51.
53. Lu J, Reese J, Zhou Y, Hirsch E. Progesterone-induced activation of membrane-bound progesterone receptors in murine macrophage cells. J Endocrinol 2015;224:183-94.
54. Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 2009;60:1743-52.
55. Pikwer M, Bergström U, Nilsson JÅ, Jacobsson L, Turesson C. Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis 2012;71:378-81.
56. Beydoun HA, el-Amin R, McNeal M, Perry C, Archer DF. Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination Survey. Menopause 2013;20:930-5.
57. Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 2003;33:72-82.
58. Orellana C, Wedren S, Kallberg H et al. Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Ann Rheum Dis 2014;73:752-5.
59. Wallenius M, Skomsvoll JF, Irgens LM et al. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis 2010;69:332-6.
60. Peschken CA, Robinson DB, Hitchon CA et al. Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American Native population. J Rheumatol 2012;39:2253-60.
61. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992;35:152-5.
62. Nagy E, Chalmers IM, Baragar FD, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991;18:1662-8.
63. Seriolo B, Ferretti V, Sulli A, Fasciolo D, Cutolo M. Serum prolactin concentrations in male patients with rheumatoid arthritis. Ann N Y Acad Sci 2002;966:258-62.
64. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004;50:3458-67.
65. Pikwer M, Bergström U, Nilsson JA et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009;68:526-30.
66. Adab P, Jiang CQ, Rankin E et al. Breastfeeding practice, oral contraceptive use and risk of rheumatoid arthritis among Chinese women: the Guangzhou Biobank Cohort Study. Rheumatology 2014;53:860-6.
67. Chen H, Wang J, Zhou W, Yin H, Wang M. Breastfeeding and risk of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2015;42:1563-9.
68. Bengtsson C, Malspeis S, Sparks JA, Costenbader KH, Karlson EW. Post-menopausal factors and the risk of seropositive and seronegative rheumatoid arthritis phenotypes: results from the Nurses' Health Study. Arthritis Rheumatol 2014;66(11 Suppl):S1261.
69. Wong LE, Huang WT, Pope JE et al. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort. Arthritis Care Res 2015;67:616-23.
70. Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol 2014;10:624-36.
71. de Melo AS, Dias SV, Cavalli Rde C et al. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction 2015;150:R11-24.
72. Canny GO, Lessey BA. The role of lipoxin A4 in endometrial biology and endometriosis. Mucosal Immunol 2013;6:439-50.
73. Du YB, Gao MZ, Shi Y, Sun ZG, Wang J. Endocrine and inflammatory factors and endometriosis-associated infertility in assisted reproduction techniques. Arch Gynecol Obstet 2013;287:123-30.
74. Harris HR, Costenbader KH, Mu F et al. Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II. Ann Rheum Dis 2016;75:1279-84.
75. Pedersen M, Jacobsen S, Klarlund M et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:R133.
76. Pedersen M, Jacobsen S, Garred P et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007;56:1446-53.
77. Cosman F, Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 1999;20:418-34.
78. Folkestad L, Bjarnason NH, Bjerregaard JK, Brixen K. The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol 2009;104:3-10.
79. Chen JY, Ballou SP. The effect of antiestrogen agents on risk of autoimmune disorders in patients with breast cancer. J Rheumatol 2015;42:55-9.
80. Szekeres-Bartho J, Barakonyi A, Par G et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001;1:1037-48.
81. Guthrie KA, Dugowson CE, Voigt LF, Koepsell TD, Nelson JL. Does pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis Rheum 2010;62:1842-8.
82. Orellana C, Saevarsdottir S, Klareskog L et al. Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study. Eur J Epidemiol 2015;30:449-57.
83. Doran MF, Crowson CS, O'Fallon WM, Gabriel SE. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004;31:207-13.
84. Orellana C, Klareskog L, Alfredsson L, Bengtsson C. Breastfeeding, oral contraceptive and the risk of rheumatoid arthritis: results from the Swedish Epidemiological Investigation of RA Study [abstract]. Arthritis Rheumatol 2015;67(Suppl 10):Abstract No. 2023.
85. Jørgensen KT, Harpsøe MC, Jacobsen S, Jess T, Frisch M. Increased risk of rheumatoid arthritis in women with pregnancy complications and poor self-rated health: a study within the Danish National Birth Cohort. Rheumatology 2014;53:1513-9.
86. Chen Q, Jin Z, Xiang C et al. Absence of protective effect of oral contraceptive use on the development of rheumatoid arthritis: a meta-analysis of observational studies. Int J Rheum Dis 2014;17:725-37.
87. Jørgensen KT, Pedersen BV, Jacobsen S, Biggar RJ, Frisch M. National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia? Ann Rheum Dis 2010;69:358-63.
88. Walitt B, Pettinger M, Weinstein A et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum 2008;59:302-10.
89. Spector TD, Roman E, Silman AJ. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990;33:782-9.
90. Pladevall-Vila M, Delclos GL, Varas C et al. Controversy of oral contraceptives and risk of rheumatoid arthritis: metaanalysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 1996;144:1-14.
91. Szarewski A, Mansour D, Shulman LP. 50 years of ''The Pill'': celebrating a golden anniversary. J Fam Plann Reprod Health Care 2010;36:231-8.
92. Sparks JA, Chen CY, Hiraki LT et al. Contributions of familial rheumatoid arthritis or lupus and environmental factors to risk of rheumatoid arthritis in women: a prospective cohort study. Arthritis Care Res 2014;66:1438-46.
93. Gatto NM, Deapen D, StoyanoffS et al. Lifetime exposure to estrogens and Parkinson's disease in California teachers. Parkinsonism Relat Disord 2014;20:1149-56.
94. Atsma F, van der Schouw YT, Grobbee DE, Kors JA, Bartelink ML. Lifetime endogenous estrogen exposure and electrocardiographic frontal T axis changes in postmenopausal women. Maturitas 2009;63:347-51.
95. Smith-Bouvier DL, Divekar AA, Sasidhar M et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008;205:1099-108.
96. Rak JM, Maestroni L, Balandraud N et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009;60:73-80.
97. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 2004;103:1190-3.
98. Gomez A, Luckey D, Taneja V. The gut microbiome in autoimmunity: sex matters. Clin Immunol 2015;159:154-62.
99. Gerlag DM, Norris JM, Tak PP. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment. Rheumatology 2016;55:607-14.